The most common molecular subtype was Luminal B human epidermal growth factor receptor 2 negative (HER2–) (n = 102; 37.2%), followed by Luminal A (n = 78; 28.5%), triple negative breast cancer (TNBC) (n = 51; 18.6%), and Luminal B (HER2+) (n = 28; 10.2%) Table 4. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.